Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
03/14/2023 | Allogene Therapeutics, Inc. | ALLO | Payment of Exercise | Common Stock | 23.6k | $5.67 | $134k | | 03/14/2023 |
02/13/2023 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 3k | $6.85 | $20.6k | | 02/13/2023 |
01/17/2023 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 3k | $7.04 | $21.1k | | 01/17/2023 |
12/15/2022 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 5.6k | $7.53 | $42.2k | | 12/15/2022 |
03/23/2022 | Allogene Therapeutics, Inc. | ALLO | Grant | Common Stock | 175.4k | $0.00 | $0 | | 03/23/2022 |
03/23/2022 | Allogene Therapeutics, Inc. | ALLO | Grant | Stock Option (Right to Buy) | 272.4k | $9.69 | $2.6M | | 03/23/2022 |
03/15/2022 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 8.8k | $7.68 | $68k | | 03/15/2022 |
09/15/2021 | Allogene Therapeutics, Inc. | ALLO | Exercise | Stock Option (Right to Buy) | 5k | $2.27 | $11.4k | | 09/15/2021 |
09/15/2021 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 5k | $24.77 | $123.8k | | 09/15/2021 |
07/15/2021 | Allogene Therapeutics, Inc. | ALLO | Exercise | Stock Option (Right to Buy) | 5k | $2.27 | $11.4k | | 07/15/2021 |
07/15/2021 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 5k | $21.55 | $107.8k | | 07/15/2021 |
06/15/2021 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 5k | $25.32 | $126.6k | | 06/15/2021 |
06/15/2021 | Allogene Therapeutics, Inc. | ALLO | Exercise | Stock Option (Right to Buy) | 5k | $2.27 | $11.4k | | 06/15/2021 |
05/18/2021 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 5k | $30.00 | $150k | | 05/18/2021 |
05/18/2021 | Allogene Therapeutics, Inc. | ALLO | Exercise | Stock Option (Right to Buy) | 5k | $2.27 | $11.4k | | 05/18/2021 |
05/17/2021 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 5k | $28.30 | $141.5k | | 05/17/2021 |
05/17/2021 | Allogene Therapeutics, Inc. | ALLO | Exercise | Stock Option (Right to Buy) | 5k | $2.27 | $11.4k | | 05/17/2021 |
04/15/2021 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 9.4k | $32.01 | $300.7k | | 04/15/2021 |
04/15/2021 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 606 | $32.64 | $19.8k | | 04/15/2021 |
04/15/2021 | Allogene Therapeutics, Inc. | ALLO | Exercise | Stock Option (Right to Buy) | 10k | $2.27 | $22.7k | | 04/15/2021 |
03/15/2021 | Allogene Therapeutics, Inc. | ALLO | Exercise | Stock Option (Right to Buy) | 10k | $2.27 | $22.7k | | 03/15/2021 |
03/15/2021 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 400 | $38.15 | $15.3k | | 03/15/2021 |
03/15/2021 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 9.6k | $37.79 | $362.8k | | 03/15/2021 |
03/15/2021 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 6.6k | $38.16 | $252.7k | | 03/15/2021 |
12/17/2020 | Allogene Therapeutics, Inc. | ALLO | Exercise | Stock Option (Right to Buy) | 51.5k | $2.27 | $116.9k | | 12/17/2020 |
10/06/2020 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 10k | $40.00 | $400k | | 10/06/2020 |
10/06/2020 | Allogene Therapeutics, Inc. | ALLO | Exercise | Stock Option (Right to Buy) | 10k | $2.27 | $22.7k | | 10/06/2020 |
10/01/2020 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 8k | $37.03 | $295.7k | | 10/01/2020 |
10/01/2020 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 800 | $37.73 | $30.2k | | 10/01/2020 |
10/01/2020 | Allogene Therapeutics, Inc. | ALLO | Exercise | Stock Option (Right to Buy) | 25k | $2.27 | $56.8k | | 10/01/2020 |
10/01/2020 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 16.2k | $36.21 | $587.1k | | 10/01/2020 |
09/01/2020 | Allogene Therapeutics, Inc. | ALLO | Exercise | Stock Option (Right to Buy) | 25k | $2.27 | $56.8k | | 09/01/2020 |
09/01/2020 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 400 | $35.89 | $14.4k | | 09/01/2020 |
09/01/2020 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 24.6k | $35.35 | $869.6k | | 09/01/2020 |
08/03/2020 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 15.1k | $36.46 | $550.7k | | 08/03/2020 |
|